← Back to headlines
Inhibrx Stock Rises After Stifel Issues 'Buy' Rating
Inhibrx shares gained value after Stifel analysts issued a new 'Buy' rating for the company, based on the performance of its lead assets.
8 Apr, 16:10 — 8 Apr, 16:10
Sources
Showing 1 of 1 sources
